Center for Cognitive and Memory Disorders

College of Medicine
Department of Neuroscience

Google scholar articles
PubMed articles

Graves Hall 4066D
333 W. 10th Ave.
Columbus, Ohio 43210
Phone: 614-688-5433

Research Interests: Neurodegenerative diseases

Research Goals: Investigating the role of glutamate transporter EAAT2 in the regulation of synaptic function and plasticity and in the pathogenesis of neurological disorders

Current Research: Development of small-molecule activator of glutamate transporter EAAT2 translation for the treatment of neurological disorders

Research Techniques: general biochemical, molecular and cellular techniques

Active Funding:

  1. The Alzheimer’s Drug Discovery Foundation
  2. The BrightFocus Foundation
  3. The ALS Association
  4. The Harrington Discovery Institute

Background: Dr. C Glenn Lin completed his doctorate in Molecular Biology and Biochemistry at the Johns Hopkins University in 1995. He performed postdoctoral research in the Department of Neurology at the Johns Hopkins University. Dr. Lin joined the Department of Neuroscience at the Ohio State University in 1999, where he directed his research to molecular mechanisms underlying neurodegenerative diseases including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS) and epilepsy.

Education: PhD, Johns Hopkins University

Honors: 2014 Alzheimer’s Drug Discovery Harrington Scholar

Share this Page